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This report includes three separate studies in different areas of synthetic biology. 
 
The first study’s aim was to investigate the potential use of Transcription Activator-Like Effectors (TA-
LEs) as custom-built artificial transcription factors for use in synthetic gene regulatory networks in pro-
karyotes. A TALE was assembled from subunits to bind the lac operator sequence. This was expressed 
from an inducible expression plasmid in E.coli and was able to repress expression of green fluorescent 
protein from a reporter plasmid. 
 
The second study aimed to design a synthetic gene regulatory network split between two separate micro-
bial strains which could regulate the population densities of both strains. The design was tested in silico 
and its functioning and parameter ranges were modelled. 
 
The third study was concerned with the goal of manipulating meiotic recombination in plants, by using 
the CRISPR/Cas9 gene editing system to create breaks in aligned homologous chromosomes during mei-
osis. A test system in Arabidopsis was devised. A sgRNA:Cas9 construct was assembled and replication of 
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 Transcriptional Regulation in Bacteria using TALEs 
 
ABSTRACT 
When building synthetic gene regulatory networks, the complexity that can be achieved is limited by the number 
of  different transcription factors (TFs) available. To build truly complex circuits we would require many TFs with 
binding sequences orthogonal to one another and also to the chassis' native TFs. Ideally these TFs would have a 
range of  strengths to allow tuneable control of  gene expression. Transcription activator-like effectors (TALEs) are 
modular proteins that can be designed to predictably bind any desired DNA sequence. TALEs can therefore be 
exploited to create synthetic transcription factors.  
We assembled a TALE, using a custom TALE kit, specific to the lac operator sequence. We created an expression 
plasmid with our TALE expressed from the inducible araBAD (PBAD) promoter, and a reporter plasmid with the lac 
operator sequence between the lacUV5 promoter and a sfGFP reporter gene. 
Cells containing the TALE expression plasmid had up to a 50-fold reduction in fluorescence compared to cells 
with the reporter plasmid only. This reduction was similar to that achieved with the wild type LacI repressor protein 
expressed from the same plasmid. The reduction increased with increasing concentrations of  arabinose, which 
induces the PBAD promoter. The results strongly suggest that our TALE successfully binds the lac operator sequence, 
repressing expression of  GFP. Our long-term goal is to produce a library of  orthogonal, synthetic repressor and 
activator TFs, built de novo utilising TALEs as the DNA binding domain and pairs of  alpha helical coiled-coils to 
mediate protein-protein interactions. 
 
BACKGROUND 
Synthetic Transcription Factors 
One aim of  synthetic biology is to build gene regulatory networks, analogous to electrical circuits, to perform 
desired functions and to explore the properties of  natural networks (1). Networks have been built to perform a 
range of  functions including logic operations (2), pattern formation (3), edge detection (4) and cancer cell detection 
(5) to name just a few. The regulation in synthetic gene networks is often applied at the transcriptional level, using 
transcription factors (TFs) (1). The complexity of  the networks that can be built is therefore limited by the number 
of  independent TFs available (6). As an analogy, it is like building an electrical circuit with only a handful of  switches 
or transistors. To confound matters, existing TFs are often native to the chassis cell and so have unwanted interfer-
ence with the cells’ endogenous gene regulation (7). Only half  a dozen or so transcription factors are regularly used 
in synthetic biology projects, even for the well-characterised Escherichia coli. This starkly contrasts with the hundreds 
of  TFs involved in the cell's endogenous regulation (8). In order to build truly complex gene networks, we would 
need to be able to independently control the expression of  many genes in parallel (9). Ideally, we would have libraries 
of  hundreds of  transcription factors (TFs), and other regulatory devices, with a range of  activity strengths, all 
orthogonal to the chassis’ regulatory proteins and to one another.  
Three possible approaches to increase the number of  available TFs would be: i) appropriate more TFs from 
nature. This has regularly been the source of  new TFs, for example TetR or LuxR (8). Limitations of  this approach 
are the work required to isolate and characterise the TFs, and compatibility issues with different chassis. ii) Well 
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characterised TFs can be modified through mutagenesis and directed evolution to alter their DNA recognition 
sequence or signal molecule (10). Again, this approach might involve considerable effort screening mutants, and 
there are likely to be limitations in how much proteins can be altered. iii) Create synthetic TFs. This option has the 
advantage that TFs could be designed to bind synthesised DNA sequences not used in natural gene regulation (11).  
 
Synthetic TFs have been constructed by several synthetic biology research groups (6, 7, 11-17). A synthetic TF 
crucially needs a method of  binding DNA, and for activators, a transcriptional activation domain. Zinc-fingers and 
more recently TALEs and CRISPR/Cas9 systems have been utilised to specifically bind a desired DNA sequence 
(8, 9). Transcription Activator-Like Effectors (TALEs) are an attractive means to develop artificial TFs, because 
they are modular proteins that can be assembled to bind potentially any specified DNA sequence (13). A species-
compatible activation domain can be fused to the TALE. These characteristics have led to TALEs being rapidly 
adopted for range of  research purposes, and kits have been developed for the assembly of  custom TALEs, by 
several research groups (11, 12, 18).  
TALEs 
TALEs are a group of  proteins produced by proteobacteria of  the genera Xanthomonas and Ralstonia. TALEs were 
originally discovered in Xanthomonas, many species of  which are plant pathogens and cause a range of  economically 
important crop diseases (19). It was serendipitous that research into the mechanism of  Xanthomonas infection led 
to the discovery of  TALEs with their potential for application in molecular biology. During infection, TALEs are 
injected into the plant cell via needle like structures of  the type 3 secretion system. By binding to the plant’s DNA 
and activating certain genes, TALEs manipulate the host cell to the benefit of  the bacteria (19).  
 
Wild type TALEs consist of  an N-terminal region containing a type III secretion signal; a central modular DNA-
binding domain, referred to as the central tandem repeat (CTR) domain or central repeat domain; and a C-terminal 
region which includes nuclear localisation signals and an acidic transcriptional activation domain (19). The CTR 
domain consists of  multiple consecutive repeats of  a conserved 34 residue sequence. The number of  repeats varies 
between TALEs but always ends with a half-repeat of  around 20 residues. Residues 12 and 13 of  the 34 residues, 
referred to as the repeat variable di-residue (RVD), differ between repeats and determine the nucleotide preferen-
tially bound. The predictable match between the two amino acids in the RVD and the nucleotide bound was eluci-
dated computationally and experimentally (20, 21). Crystal structures later revealed that the CTR forms a right 
handed super-helix that coils around double stranded DNA, with the RVDs facing inwards to interact with nucle-
otides in the major groove (Figure 1) (22, 23). Residue 12 forms hydrogen bonds with the TALE backbone that 
stabilise the structure; residue 13 contacts the sense DNA strand to form hydrogen bonds or van der Waals inter-
actions with a specific nucleotide (22, 23): the RVDs HD and NN form hydrogen bonds with their nucleotide, and 
RVDs NI and NG form weaker van der Walls interactions (24). The CTR domain alone does not strongly bind 
DNA, and part of  the N-terminal region adjacent to the CTR is known to contain a number of  repeats which also 
form a super-helix. These repeats form very similar structures to the CTR repeats and bind DNA non-specifically 









Figure 1. Structure of  a TALE CTR bound to DNA, individual repeats are shown in different colours. Image 
taken from (23).  
 
Their modularity and predictable specificity mean that TALEs can theoretically be designed for any desired DNA 
sequence. The activation domain can be replaced by other functional domains to give TALEs numerous applications 
(26). Artificial TALEs usually have truncated N- and C-terminals. The first 152 residues of  the N-terminal region 
encode the secretion signal and so are unnecessary for most applications (13). The C-terminal region has been 
shown to be largely non-essential for DNA binding and is often truncated to 63 residues (13). The half  repeat is 
usually included, but one study has suggested that it is an evolutionary artefact rather than a functional necessity 
(27). CTRs, by necessity, begin with a thymine binding RVD called the zero repeat (9). The first RVD-nucleotide 
correspondences deciphered were NI - A, HD - C, NG - T and NN - G (20, 21); NN will also bind A. An alternative 
RVD NK has higher specificity for G but lower affinity, whilst another alternative NH has improved specificity and 
affinity; however, most TALE designs have stuck with the original NN (9).  
 
Artificial TALEs have been used successfully in a constantly growing list of  eukaryote species, including mammals 
and plants (14, 15, 18, 26). TALEs have been fused to transcriptional activation domains and nucleases (15, 18). 
Surprisingly, there are few reports of  artificial TALEs used to target genes in prokaryotes (28), but the potential to 
use TALEs to modify gene expression in prokaryotes has been demonstrated (6, 7, 15). Politz and colleagues suc-
cessfully showed that an expressed TALE could bind to the lac operator and repress the expression of  a downstream 
fluorescent reporter protein (28). Repression achieved was greater than that with the native LacI repressor protein. 
The TALE was designed to bind 19 base pairs of  the lac operator O1 sequence (29), and the DNA coding for the 
TALE was commercially synthesised (28). Our aim was to build on the study of  Politz and colleagues by assembling 
TALEs to act as the DNA binding components of  synthetic TFs for use in prokaryotes. The first step was to 
assemble a TALE from a kit and reproduce the results reported by Politz and colleagues (28). The advantage of  
assembling the TALE from a modular kit, rather than having the DNA synthesized, is that once assembly and assay 
methodologies have been established, any number of  TALEs can then be assembled economically in the same 
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manner for orthogonal DNA sequences. Our long-term goal is to produce a library of  orthogonal, synthetic re-
pressor and activator TFs, built de novo utilising TALEs as the DNA binding domain and pairs of  alpha helical 
coiled-coils to mediate protein-protein interactions, and to exploit these transcription factors for the creation of  






MATERIALS AND METHODS 
TALE Assembly 
A DNA sequence coding for a TALE complementary to 19 base pairs of  the wild type lac operator O1 sequence 
(5’-TGTGAGCGGATAACAAT-3’) was designed and assembled as described in (29). The assembly involved a 
series of  hierarchical cloning steps to build a repeat array from its constituent single repeat modules (Figure 2). 
The TALE construct (TALElac01) was assembled from a plasmid kit available from the Joung group (Addgene kit 




Figure 2. Schematic of  the assembly of  the 17-repeat array, showing the 5 hierarchical ligation steps to 
produce the array.  A 16-repeat array minus TAL Unit 40 was cloned into the expression plasmid (before ligation 5 
was carried out). The Image is taken from ZiFit software used to design the TALE (34). 
 
Briefly: two plasmids containing the N- and C-terminal TALE repeats to be ligated were restriction digested in a 
40µl total volume. The N-terminal plasmid backbone and C-terminal TALE repeat fragment were isolated by gel 
electrophoresis and purified. The C-terminal fragment was ligated into the N-terminal backbone. Chemically com-
petent XL1Blue cells (Stratagene, 200249) were transformed with ligation products and grown on Luria-Bertani 
(LB) agar  plates (Sigma-Aldrich, L7025), supplemented with 100 µg ml-1 carbenicillin (Thermo Fisher, 10177012), 
for 14 hours. 4 individual colonies were inoculated into LB broth (Sigma-Aldrich, L7275) supplemented with 100 
µg ml-1 carbenicillin and grown for 14 hours. Plasmid DNA was purified using QIAprep Spin Miniprep Kit 
(QIAGEN, 27104), restriction digested and separated by gel electrophoresis to check that the insert size was correct. 
Five sequential cloning steps were required to assemble a 17-repeat length array, which was then cloned into an 


















cloning steps of  the assembly followed the kit protocol, with the following modifications: The digested N-terminal 
backbone was phosphatase treated at each step, to reduce the chance of  the ends ligating — 2 µl Alkaline phospha-
tase (Calf  intestinal) (NEB, M0290S), 5µl of  10 X Alkaline Phosphatase buffer, and 3 µl ddH2O were mixed with 
the restriction digest to give 50 µl total volume and incubated at 37°C for 1 hour; polyacrylamide gels were replaced 
with agarose gels for electrophoresis, with gel extractions carried out using QIAEX II Gel Extraction Kit 
(QIAGEN, 20021); and standard T4 DNA Ligase buffer (NEB, B0202S) was used in place of  quick ligase buffer. 
pBAD-His-JDS78 Expression Plasmid Assembly 
Our expression vector design required TALE N- and C-terminal regions downstream of  the PBAD promoter, to 
create a plasmid that would serve as a backbone for insertion of  the TALE repeat array between the two terminal 
regions (Table 1 shows details of  all plasmids and primers used in this study).  
We designed primers pBAD01 and pBAD02 for contiguous sequences including a BsmBI restriction site in the 
pBAD-His-RFP plasmid (Addgene, #31855), to amplify the whole plasmid. One primer included two mismatched 
bases to mutate out the BsmBI restriction site. The PCR mix contained: 5 µl 10 Pfu buffer, 1 µl 10 µM dNTPs, 2 
µl 10 µM forward and reverse primers, 25 ng template DNA and 0.5 µl Pfu polymerase in a 50 µl final volume 
(reagents from Promega).  Thermo-cycle conditions were: 98°C – 3 minutes, then 16 cycle of  95°C – 30 seconds, 
60°C – 1 minute, 68°C – 10 minutes, followed by 68°C – 10 minutes. PCR product was mixed with 5 µl DpnI 
(NEB) and incubated at 37°C for 2 hours, then purified using a QIAGEN QIAquick PCR Purification Kit. 100 µl 
of  XL1 Blue cells were mixed with 5 µl of  the purified PCR product and incubated on ice for 30 minutes. The 
mixtures were heat shocked at 42°C for 2 minutes then returned to ice for 1 minute. 400µl of  LB media was added 
and cells were recovered with agitation for 45 minutes at 37°C. Transformations were centrifuged at 13000rpm for 
1 minute and most of  the media was removed. Cells were re-suspended and 200µl of  culture grown on LB plates 
supplemented with ampicillin 100µg ml-1 with agitation 300rpm, at 37 °C for 14 hours. 4 individual colonies were 
inoculated into 5 ml LB media supplemented with ampicillin 100 µg ml-1 and grown with agitation 300rpm, at 37 
°C for 14 hours. Plasmid DNA was purified using a QIAGEN QIAprep Spin Miniprep Kit.  
In order to add compatible restriction sites to the TALE N- + C- terminal sequence from Plasmid JDS78, a 
second set of  primers LCTAL01.C.F and LCTAL01.C.R were designed to amplify the TALE sequence minus the 
FOKI domain. The primers had overhangs that included BglII and HindIII recognition sequences at the N- and 
C- termini respectively. The PCR mix was as above. Thermo-cycle conditions were: 98°C – 5 minutes, then 30 cycle 
of  94°C – 1 minute, 55°C – 1 minute, 72°C – 2 minutes, followed by 72°C – 10 minutes. The product was DpnI 
digested and purified as above.  
The restriction-site-deleted pBAD-His-RFP plasmid and JDS78 TALE PCR product were restriction digested 
with NEB BglII and HindIII (NEB). The pBAD-His-RFP backbone and JDS78 TALE fragment were isolated by 
gel electrophoresis, ligated, transformed and purified as above. Finally the 16 repeat length array was cloned into 
pBAD-His-JDS78 to create plasmid pBAD-His-TALElac01 (Figure 3) following the protocol from (30).
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Table 1. List of  Plasmids and Primers used. 
 
Plasmid ID Description Insert Source 
pBAD-His-B-iRFP Used as base for TALE/LacI expression plasmids iRFP Addgene  
pBAD-His-JDS78 Backbone for expression of  TALE repeat arrays TALE N- and C-terminal regions This study 
pBAD-His-TALE-
lac01 
Expression of  TALE TALElac01 construct This study 
pBAD-His-LacI Expression of  LacI (wt) lacI Dr Abby Smith 
TAL10 - TAL40 TALE repeat array assembly Individual TALE repeats (30) 
JDS78  Complete TALE Assembly TALE N- and C-terminal regions (30) 
pVRbLacUV5 Reporter plasmid for lac operator binding LacUV5 SfGFP Dr Abby Smith 
Primer ID Sequence (5’ to 3’) Purpose 
LCTAL01.C.F CGAGTCAGATCTGTGGACTTGAGGACACTCGG Added restriction sites to JDS78 TALE sequence to clone into pBAD-His-B-iRFP 
LCTAL01.C.R TGCGAGAAGCTTTTACGCGACTCGATGGGAAG Added restriction sites to JDS78 TALE sequence to clone into pBAD-His-B-iRFP 
pBAD01 GCTGTGACCGATTCCGGGAGCTGC Mutagenic PCR to delete restriction site from pBAD-His-B-iRFP 
pBAD02 GCAGCTCCCGGAATCGGTCACAGC Mutagenic PCR to delete restriction site from pBAD-His-B-iRFP 
pBAD-LC-F GCATGACTGGTGGACAGC Sequencing insert in pBAD-JDS78 
pBAD-LC-R AGACCGCTTCTGCGTTC Sequencing insert in pBAD-JDS78 
JDS2978 TTGAGGCGCTGCTGACTG Sequencing insert in pBAD-JDS78 
JDS2979 AAGCAATGGCGACCACCTGTTC Sequencing insert in pBAD-JDS78 
M13 uni (-21) TGTAAAACGACGGCCAGT Sequencing insert in TAL10 and TAL29 





Figure 3. Plasmid map showing the final expression plasmid pBAD-His-TALElac01, including the com-
plete TALE sequence downstream of  the PBAD promoter. T = terminator, AmpR = Ampicillin Resistance, CTR = 
Central Tandem Repeat domain of  TALE, ori = origin of  replication, RBS = Ribosome Binding Site, BOM = Basis 
of  Mobility region. 
Sequence Verification 
Assembled TALE repeat arrays were sequence verified at the 8 and 17 repeat array stages, by PCR amplifying the 
array from assembly kit plasmids TAL10 or TAL29, using forward primer M13 uni (-21) and reverse primer M13 
rev (-29) (See (30) for further details). The final TALElac01 insert in the pBAD-His-TALElac01 plasmid was 
sequence verified from two start points using forward primers pBAD-LC-F and JDS2978 and reverse primers 
pBAD-LC-R and JDS2979. Sequences were aligned using GSL Biotech SnapGene Software. A combination of  
clear reads from the 4 pBAD-His-TALE primers gave a complete correct TALE sequence. 
pVRblacUV5 and pBAD-His-LacI Plasmids 
pVRblacUV5 (Figure 4) and pBAD-His-LacI (Figure 5) plasmids were constructed by Dr Abby Smith for a 
previous study.  pVRblacUV5 was derived from pVRb220 (31) and had the promoter upstream of  sfGFP replaced 
with the lacUV5 promoter including the lac operator sequence. pBAD-His-LacI was derived from pBAD-His-RFP 
and had the RFP gene replaced with the LacI gene.  
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Fluorescence Assays 
100µl of  chemically competent bacterial strain TB28 (32)(Genotype: ΔlacIZYA) cells were mixed with 10µl, 10nM 
of  each appropriate plasmid (pVRblacUV5, pBAD-His-LacI, pBAD-His-TALElac01) and grown on LB plates 
supplemented with the relevant antibiotic(s) (pVRblacUV5 - 50 µg ml-1 Kanamycin,   pBAD-His-LacI/pBAD-
His-TALElac01 100µg ml-1 ampicillin), for 14 hours at 37°C. Three individual colonies were inoculated into 5 ml 
LB media supplemented with the relevant antibiotic(s) and grown with agitation 300rpm at 37°C for 14 hours. 100µl 
of  culture was mixed with 10ml LB media supplemented with the relevant antibiotic(s), arabinose (0.0002 to 2 % 
w/v) and IPTG (1mM). Cultures were then incubated at 37°C 300rpm agitation. Optical density was measured 
approximately every 15 minutes. Once cells had reached exponential phase, they were stored on ice. For initial 
optimisation experiments, cells were transferred to ice when OD600 reached approximately 0.5. For the final TALE 
expression assay, cells were grown for longer until OD600 reached approximately 1.4.  5 ml of  each culture was 
centrifuged for 4 minutes at 5000rpm, 4°C. Cells were re-suspended in 200µl PBS. 100µl of  the suspension was 
added to the well of  a black Greiner 96 well plate. Fluorescence readings were taken using Molecular Devices, 
SpectraMax 190 Microplate Reader with the following settings: excitation wave length 485nm, Absorbance 510nm, 
cut-off  495nm.  
Fluorimeter Data Analysis 
Data analysis was performed with Microsoft Office Excel 2010. To account for background auto-fluorescence, 
average readings for non-transformed “empty” TB28 cells were subtracted from treatment readings. Readings were 
normalised by dividing by OD600 readings and shown relative to the highest reading for the replicate.  
 
Figure 4. Plasmid map showing the reporter plasmid pVRbLacUV5, with the Lac operator O1 sequence 
between the lacUV5 promoter and sfGFP gene. T = terminator, KanR = Kanamycin Resistance, NeoR = Neomycin 





Figure 5. Plasmid map showing the expression plasmid pBAD-His-LacI, with LacI downstream of  the 
PBAD promoter. T = terminator, AmpR = Ampicillin Resistance, ori = origin of  replication, RBS = Ribosome 
Binding Site, BOM = Basis of  Mobility region.  
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RESULTS 
TALE Expression Vector 
We constructed a TALE expression vector —  pBAD-His-JDS78 — with restriction sites between the TALE N- 
and C-terminal regions for the insertion of  any TALE repeat array. This expression plasmid includes the standard 
T-binding zero repeat and a final half  repeat, corresponding to T, and can be used for any designed repeat array — 
although the sequence must end with a T. The TALE sequence is downstream of  the inducible PBAD promoter and 
the plasmid includes the araC gene, so that in the presence of  arabinose araC induces expression from the PBAD 
promoter of  the TALE. Therefore, expression of  any TALE from the plasmid should be tightly regulated and 
inducible with arabinose. Aside from the change of  promoter, it was also necessary to create this new expression 
plasmid to omit the FOKI nuclease included in the assembly kit expression vector.  
TALE Repeat Array 
We assembled a 17 repeat length array without N- or C-terminals (Figure 2). We also cloned an array of  16 of  
the repeats into our pBAD-His-JDS78 expression plasmid to create our final complete TALE expression plasmid 
— pBAD-His-TALElac01 (Figure 3): the final repeat in the TALE was omitted, due to a shortage of  time. This 
TALE sequence was verified by sequencing and could be used in future TALE constructs, as could its constituent 
2, 4 and 8 repeat subunits.  
TALE Binding and Repression Assays 
We tested whether our TALE would bind to its target lac operator sequence by transforming E. coli cells, strain 
TB28 which has the lac repressor (LacI) gene deleted, with the pBAD-His-TALElac01 expression plasmid and 
with a GFP reporter plasmid — pVRbLacUV5. pVRbLacUV5 has the lac operator sequence between the lacUV5 
promoter and a green fluorescent protein (sfGFP) gene, therefore TALE binding at the lac operator should repress 
expression of  GFP. The repression assays included a control with the wild type LacI repressor protein expressed 
from the same plasmid as our TALE — pBAD-His-LacI.  
Prior to expression assays, we took fluorimeter readings for a range of  densities of  cells containing the reporter 
plasmid pVRbLacUV5 only, to ensure that readings had a linear relationship with fluorescence and were not be-
coming saturated at high cell density. Readings had a linear relationship for 5ml growth cultures concentrated by 
factors of  3× to 50× (Figure 6). Cells containing only the reporter construct were expected to give the highest 
fluorescence readings, and we used 25× culture concentrations in all further assays; therefore, our assayed cells were 
at densities well within the tested fluorescence readings range. 
Before conducting the final TALE repression assay, we tested GFP expression in the presence of  the pBAD-
His-LacI plasmid at different arabinose and IPTG concentrations. This was to test whether arabinose-induced-
expression from our plasmid behaved as expected, without the complication that our TALE may not function as 
expected. The addition of  IPTG should remove LacI repression and therefore provide evidence that any decrease 
in GFP expression was the result of  repression via the lac operator and not due to other factors, such as the meta-
bolic burden introduced by the additional expression plasmid. pBAd-His-LacI containing cells had a twofold re-
duction in fluorescence compared to cells with the reporter plasmid alone (Figure 7). The reduction was removed 
partially in the presence of  1mM IPTG. However, arabinose concentration appeared to have no effect. The results 
indicate that the assay system overall worked as expected. The fact that repression occurs without arabinose suggests 
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some leakiness of  the PBAD promoter. One explanation for the low level of  repression observed, and lack of  an 
effect of  arabinose concentration, is that more time was required for repression to become fully observable, perhaps 
due to the time needed to degrade accumulated GFP: cultures had only taken approximately 2.5 hours to reach 0.5 
OD600. Because of  this in the final assay, cells were grown for 4 hours, to an OD600 of  roughly 1.4 instead of  0.5.  
 
Finally, we tested cells transformed with our TALE expression plasmid pBAD-His-TALElac01. We tested the 
fluorescence of  cells grown in arabinose concentrations of  0 - 0.2 % w/v. Without arabinose, Cells transformed 
with the TALE expression plasmid (pBAD-His-TALElac01) and reporter plasmid (pVRbLacUV5) had a two-
fold reduction in fluorescence compared to cells transformed with the reporter plasmid alone (Figure 8). This 
reduction was similar to that achieved in cells transformed with the LacI expression plasmid (pBAD-His-LacI) 
plus the reporter plasmid. This suggests that the TALElac01 protein was expressed and bound the lac operator 
sequence as designed, blocking transcription of  the sfGFP gene. Fluorescence decreased further with increasing 
arabinose concentration, with a maximum 50-fold reduction at 0.2% arabinose. The graduated reduction in fluo-
rescence was very similar with LacI. This provides further evidence that the reduction of  fluorescence was indeed 






Figure 6. Fluorescence readings for different cell densities. Cells containing the sfGFP reporter plasmid 
(pVRbLacUV5).  The linear relationship between the concentration factor of  5ml cultures and fluorescence show 
that the fluorimeter readings were not saturated in this range. Diamonds show means, n = 2. Fluorescence in arbi-






















Figure 7. Fluorescence readings for cells containing GFP Reporter Plasmid Only (pVRbLacUV5) or 
Reporter Plasmid plus LacI expression plasmid (pBAD-His-LacI), with and without 1mM IPTG.  Cultures 
were grown with different Arabinose concentrations. Bars show Means ± SEM, n = 3. Fluorescence in arbitrary 
units normalised to range 0-1. 
 
Figure 8. Fluorescence readings for cells containing sfGFP Reporter Plasmid Only (pVRbLacUV5), Re-
porter Plasmid plus LacI expression plasmid (pBAD-His-LacI) or Reporter Plasmid plus TALElac01 ex-
pression plasmid (pBAD-His-TALElac01). Cultures were grown with different Arabinose concentrations. Bars 
show Means ± SEM, n = 2 for Reporter Only and Reporter plus LacI, n = 1 for Reporter plus TALElac01. Fluo-
rescence in arbitrary units normalised to range 0-1. No recording was made for TALE at 0.0002% Arabinose: due 



















































Our results support the findings of  Politz and colleagues that TALEs can be used successfully in prokaryotes 
(28). From these initial results, we cannot exclude the possibility that the change in fluorescence was a direct re-
sponse in GFP expression to arabinose concentration, although there is no obvious link between the two. Further 
controls would be needed with cells containing the reporter plasmid only grown with various arabinose concentra-
tions. It is also possible that the reduced fluorescence was not a response to repressor protein binding, but to some 
other factor caused by the presence of  the expression plasmid. To refute this possibility, experiments to would need 
to include removal of  the CTR domain of  the TALE and separately removal of  the lac operator sequence, to 
demonstrate both are necessary for reduced GFP expression; however, time was not available to include these 
additional controls. 
 
pBAD-His-TALElac01 assembly lays the foundation to create a range of  TALES using the tested assembly 
method.  Assembly of  a 17-repeat array, using the Joung Lab kit and protocol takes 5 weeks, if  everything runs 
smoothly. Our 17 repeat array required 5 sequential sets of  cloning steps and a final step to clone the array into the 
expression vector. Each step requires 4-5 days, but this can easily take longer. Because the TALEs are assembled by 
ligating pairs of  repeat arrays, 4-, 8- and 16-repeat arrays are efficient lengths to build. Our results suggest 18.5 
repeats were sufficient to bind DNA, including the zero repeat and half  repeat. Gene activation has been shown in 
plants with just 6.5 repeats and activation plateaued after 10.5 repeats (9). In future, we aim to assemble multiple 
TALEs in parallel using a liquid handling robot to speed up assembly.   
 
The pBAD-His-JDS78 expression plasmid is a useful tool to assay future TALE constructs. Any repeat array 
assembled using the Joung group kit can be cloned directly into our plasmid which includes the TALE N- and C-
terminals. The target DNA sequence needs to end with a T, because the existing plasmid contains the final half  
repeat RVD for T. However, it would be straightforward to construct plasmids for the other three nucleotides, using 
primers LCTAL01.C.F/R to amplify from other expression plasmids in the kit. Our intermediate, shorter CTR 
assemblies can also be utilised later to create TALEs for different target DNA sequences. 
 
These results are a first step toward the larger goal of  assembling a range of  synthetic repressors and activators 
based on TALEs. Unpublished work by the Savery group has used de novo designed coiled-coil pairs (33) to mediate 
interaction between a Bacteriophage lambda cI repressor protein and the alpha subunit of  RNA polymerase, creating 
a synthetic transcriptional activator. The coiled-coils are pairs of  rationally designed alpha-helix peptides that asso-
ciate through hydrophobic residues to form dimers. A set of  coiled-coil pairs has been created, with a range of  
dissociation constants (33).  The cI protein acts as the DNA binding domain of  the activator. It was expressed as a 
fusion protein with one half  of  a coiled-coil pair. The second half  of  the coiled-coil pair is expressed as a fusion 
protein with the alpha subunit of  RNA polymerase. The alpha-helix therefore acts as the activation domain of  the 
synthetic activator, recruiting RNA polymerase. By placing the cI recognition DNA sequence upstream of  a pro-
moter for a reporter protein, it was shown that the synthetic TF increased gene expression in the presence of  the 
modified alpha subunit. Activators built in this way have the same limited number of  DNA binding sites as natural 
TFs. However, by replacing the cI protein with a TALE we hope to produce a set of  orthogonal TFs in which the 
whole protein sequence is rationally designed for a specified DNA sequence.  
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The advantages of  this system would be that: The enhancer sequence could be designed to avoid off  target 
interference with the chassis species’ genome. Software exists to design TALEs to avoid off  target binding (15). A 
large number of  orthogonal enhancer-activator pairs could be designed, giving parts that could be used “off  the 
shelf ” from a library, or custom built to new specifications. The strength of  transcriptional activation would be 
tuneable via a combination of  the dissociation constants of  the coiled-coil pair and the DNA binding affinity of  
the TALE. TALE affinity can be altered by changing the number of  repeats in the CTR domain or by including 
mismatched RVDs. TALEs are known to bind DNA sequences with up to 3 base pair mismatches (15). 
Towards this goal, our next step is to create a fusion protein with TALElac01 replacing cI as the DNA binding 
domain of  a synthetic activator (Figure 9). A reporter plasmid with the lac operator upstream of  a promoter for 
sfGFP would be used to test activation strength. Another interesting extension would be to create short TALEs that 
only bind DNA cooperatively when dimerised via coiled-coils. Similar systems have been reported and allow a neat 




Figure 9. Plasmid map showing a design to incorporate one half  of  a coiled-coil pair (Coil AN3.5) into 
our existing pBAD-His-TALElac01 expression plasmid to create a synthetic activator. T = terminator, AmpR = 
Ampicillin Resistance, CTR = Central Tandem Repeat domain of  TALE, ori = origin of  replication, RBS = Ribo-
some Binding Site, BOM = Basis of  Mobility region. 
 
This system of  orthogonal TFs could potentially help solve the problems of  the shortage of  orthogonal TFs and 
interference with chassis functioning. However, one limitation is that the TFs would not directly recognise chemical 
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signals; natural TFs are often activated or inactivated by a signal molecule.  In our test system, external control of  
expression was still via the natural TF AraC and its ligand arabinose. The synthetic activators could be used as 
intermediates in regulatory networks and to create logic gates, but the networks would still rely on natural proteins 
to detect external signals.  In electronics terms it gives us the wires but not the sensors.  A solution to this problem 
was recently demonstrated by Rai and colleagues (7)  who used a combination of  TALEs and ribo-switches to 
create synthetic repressors only active in the presence of  signal molecules. Finding other solutions to this limitation 




Work All work was carried out by the student, with the exception of  construction of  the pBAD-His-LacI and 
pVRbLacUV5 plasmids, the final fluorimeter assay of  TALE repression and design of  primers pBAD01 and 
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A Population Density Regulating Synthetic Gene Network Design 
 
ABSTRACT 
 The ability to control the population densities of  multiple microbial populations simultaneously may be desirable 
for a range of  synthetic biology and biotechnology applications in which microbial consortia perform more effi-
ciently than a single strain. Many bacteria use quorum sensing based feedback systems to monitor and respond to 
changes in population density and this presents a means to create synthetic gene regulatory networks which regulate 
population density. Here we test in silico a design for a gene network, split between two populations, that implements 
negative feedback to regulate both population densities. The design was originally developed as part of  project S3.2 
at the Bristol Centre for Synthetic Biology and is adapted here to control a different population phenotype. Specif-
ically, in the design, a “master” population autonomously regulates its own density, and also acts as a controller to 
regulate the density of  the second “slave” population. Negative feedback loops in the design utilise quorum signal-
ling pathways and the toxin protein ccdB to maintain stable densities of  both populations. The steady state popu-
lation densities can be tuned via an external arabinose input. We simulated the design in silico to investigate its 
properties and parameter constraints. Our model showed that the design is able to keep population densities steady 
and that densities can be modulated as required. This proof  of  concept design could be expanded to control mul-
tiple-strain microbial consortia.  
 
BACKGROUND 
One aim of  synthetic biology is to build gene regulatory networks, analogous to electrical circuits, to perform 
desired functions and to explore the properties of  natural networks (1). A great deal of  progress has been made in 
engineering single cells to perform new functions, for example chemical production, logic operations, cancer cell 
detection and sensing (2-5). While the majority of  studies have created synthetic circuits embedded in single cells, 
the complexity and efficiency that can be achieved may be increased by engineering multicellular systems in which 
functionality is distributed amongst cells (6, 7). Multicellular systems provide the following advantages: the meta-
bolic burden placed on cells, by introducing biological components, can be shared between strains, potentially al-
lowing more complex circuits to be assembled (8); stochasticity resulting from intrinsic variation between individual 
cells may be smoothed out, if  signals are taken as the averages from many cells (9); and certain natural properties 
of  a species may be impossible to introduce into another species, and therefore the only way to combine properties 
may be to have multiple species growing together (7). 
Population Density Regulation   
For many potential applications of  microbial consortia, it would be necessary to regulate population density reli-
ably, in terms of  both absolute density and the ratios between individual populations (6). Engineered autonomously-
regulating cells could achieve this population control and alleviate some of  the need for constant external regulation 
of  growth conditions. In fermentation or pharmaceutical production, for instance, it could be important to keep 
bacterial strains at set densities to prevent the build-up of  toxic metabolites reducing growth, or to optimise the 
efficiency of  a process. Autonomously regulating bacterial populations could also be applied as therapeutics (7, 10); 
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an engineered bacterial strain could be introduced into a patient, which would thereafter maintain its own density 
and release a therapeutic at the correct rate. Ideally, for a hypothetical synthetic consortium, population densities 
would autonomously remain steady and would be tuneable via external inputs. Multicellular systems require inter-
cellular communication for coordinated behaviour (11), and in bacteria this is usually achieved by quorum sensing 
(QS) systems (12). Quorum sensing describes a coordinated response in bacteria to changes in population density. 
Quorum sensing bacteria release signalling molecules — known as autoinducers — into their surroundings, which 
at a threshold concentration trigger cascades of  gene regulation. In general, the autoinducers of  gram-negative 
bacteria are N-acyl homoserine lactones — (NA)HSLs — which differ in the number of  carbon atoms in the side 
chain.  
The canonical quorum sensing system is that of  the bioluminescent bacterium Aliivibrio fischeri (formerly Vibrio 
fischeri)  which lives symbiotically within the Hawaiian bobtail squid, Euprymna scolopes (as well as within other marine 
species). When the bacteria live at high densities, within the light-organ of  the squid, a selective advantage is gained 
from luminesce: which camouflages the squid against the sky, from predators below.  
The quorum sensing system of  A. fischeri comprises of  the enzyme LuxI, that catalyses production of  the auto-
inducer N-(3-oxohexanoyl)-homoserine lactone (3OC6HSL), and the 3OC6HSL inducible transcription factor 
LuxR, which upon binding 3OC6HSL activates expression from the luxICDABE operon which encodes the com-
ponents of  luciferase (Figure 1). Many other quorum sensing systems have been elucidated, which in gram-negative 
bacteria generally function in the same way, with homologues of  LuxI and LuxR, and differing N-homoserine 
lactone autoinducers.   
 
 
Figure 1. The quorum sensing system of  Aliivibrio fischeri. Showing The N-acyl homoserine lactone syn-
thase LuxI producing N-(3-oxohexanoyl)-homoserine lactone 3OC6HSL (grey hexagons), which activates the 
transcription factor LuxR, which in turn both activates transcription of  the luxICDABE operon and represses 




Synthetic multicellular networks have already been created utilising QS for inter-cellular signalling (13). For ex-
ample, Danino and colleagues used QS to synchronise oscillatory bursts of  bioluminescence in Escherichia coli, 
demonstrating the ability to use signalling to synchronise cell behaviour (14). Basu and colleagues used QS to pro-
duce spatial patterns of  fluorescent protein production, using two strains containing different synthetic gene circuits 
(15). 
Feedback Control Systems  
In order to have cells autonomously regulating their population density, closed-loop feedback is required (16). 
Negative feedback regulation is ubiquitous in nature where it is necessary for homoeostasis (17). Organisms con-
stantly need to adapt to changes in internal processes as well as in their environment, and this adaptation is often 
the result of  negative feedback. Negative feedback occurs at all levels of  biological complexity from cellular pro-
cesses to sensory-motor control and even into ecological interactions (17). In yeast cells, changes in turgor pressure 
at the cell membrane trigger a rise in glycerol synthesis via a signalling cascade. The resulting change in the osmo-
larity of  the cytosol balances the change in the environment and therefore returns turgor pressure to normal (18). 
Hawk moths constantly use feedback from visual stimuli and alter the shape of  their abdomen to control pitch in 
order to sustain hovering flight while feeding (19). Flapping flight is intrinsically noisy and sensitive to external 
perturbation from air currents, so without feedback it would be a highly haphazard way to move around (17). At an 
ecological level, oscillations in predator prey systems resulting from over predation and feedback via prey scarcity 
are well-documented phenomena (20).  
 
Just as in nature, feedback control is long established in engineering and control theory has developed to provide 
a formal mathematical framework to study it. In a typical control scheme (Figure 2), the output (y) of  a controlled 
system, referred to as the plant, is measured by a sensor. This measured output (ŷ) is compared to an external 
reference value (r) by a comparator, which then passes the calculated error (e) to a controller. The controller then 
calculates a correctional signal (û) to be implemented by an actuator as a system input (u) to steer the controlled 
system back to the desired output level. Control theory is often used in synthetic biology to design stable and robust 
gene regulatory networks (GRNs) (21). Negative feedback has been used to build oscillators and positive feedback 
has been used to create bi-stable switches (14, 22, 23). One way to implement feedback regulation in engineered 
cells is to use an external control system. This approach has been demonstrated in a number of  recent studies, in 
which a control algorithm implemented in a computer was combined with real time in vivo measurements to create 
a closed loop and steer a biological process to a specified level. Milias-Argeitis and colleagues used red and far red 
light as inputs to trigger PhyB-PIF3 mediated expression of  a fluorescent protein in yeast (24).  The system output, 
fluorescence, was measured using flow cytometry and a computer algorithm calculated the control input.  Meno-
lascina and colleagues demonstrated a similar system in which time-lapse microscopy was used to measure the 
fluorescence of  yeast cells grown in a microfluidics device (25). A computer algorithm calculated the regulatory 
input of  adding glucose or galactose.  
 
There have also been several examples of  synthetic circuits implemented in vivo to regulate population density.  A 
single population was engineered by You and collegues (26) to achieve a stable low density over a long period of  
time, using a QS molecule to activate expression of  a toxin protein. Following on from this work, Balagadde and 
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colleagues created an artificial predator prey system in which two engineered strains interacted via QS molecules to 
attain stable or oscillatory population dynamics, depending upon media conditions (27). These studies demonstrate 
the opportunity to utilise QS molecules and toxin-antitoxin proteins to manipulate bacterial cell densities, and to 
apply this for useful purposes. 
 
 
Figure 2. Block diagram of  a typical control scheme. Showing the necessary components of  a control system 
and the symbols assigned to inputs and outputs. 
 
Study Aims 
Building on the work of  You, Balagadde and colleagues (26, 27), the aim of  this study was to design a synthetic 
GRN able to control the population densities of  two different bacterial strains. The objective was to have one strain 
acting as the “master” population, maintaining its own density as well as sensing and controlling the population 
density of  the second “slave” strain, with the additional objective that both population densities are tuneable via an 
external reference input sensed by the master cells. To achieve these goals, the design uses closed-loop negative 
feedback implemented within the cells. The interaction between master and slave populations can therefore be 
viewed in terms of  a classical control feedback system with the master population carrying out the sensor, compar-
ator and controller functions and the slave population acting as the plant and containing the actuator. Two popula-
tions were modelled as a proof  of  concept but the general design could be modified for multiple populations 
cultured together in a synthetic consortium with one population regulating the density of  the other populations or 
alternatively with a cascade of  hierarchical control.  
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RESULTS AND DISCUSSION 
Circuit Design 
Our circuit design consists of  two closed loops (Figure 3): the first loop (Labelled L1 in Figure 3) uses QS 
signalling between master and slave cells and a toxin protein ccdB to create a negative feedback loop regulating slave 
population density. We used a modification of  a circuit designed by Balagadde and colleagues, as its functioning has 
been confirmed in vivo (27). The circuit uses two QS systems: the LuxI/LuxR system from the marine bacterium 
A. fischeri and the LasI/LasR system from Pseudomonas aeruginosa (28). In both systems, the inducer protein 
(LuxI/LasI) synthesises a small diffusible Homoserine Lactone HSL. The HSL activates its cognate receptor protein 
(LuxR/LasR) which acts as a transcriptional regulator and increases gene expression from the PluxI promoter (both 
LuxR and LasR are known to up-regulate expression from PluxI (27), so we used the promoter in both systems).  
When it accumulates in the cytosol, ccdB protein acts as a poison in E.coli, interfering with the DNA gyrase complex 
(29). In our design, slave cells constitutively express LuxI which synthesises 3OC6HSL, this diffuses into the sur-
rounding media and then into master cells. At sufficient concentration, 3OC6HSL alters LuxR conformation to its 
active state. LuxR then upregulates expression of  LasI; LasI in turn catalyses the synthesis of  another HSL: 
3OC12HSL, which diffuses into slave cells and activates LasR. Finally, LasR increases expression of  ccdB, poisoning 
a proportion of  slave cells, this closes the loop by reducing slave population growth, and therefore 3OC6HSL 
production. LuxR and LasR are constitutively expressed.  
The second loop in the design (Labelled L2 in Figure 3) is required to maintain a stable master population density. 
Unlike the predator prey system of  Balagadde, we needed the master population to regulate its own density inde-
pendently of  slave population density. A similar QS - ccdB negative feedback loop is used to regulate master pop-
ulation density, utilising another QS system, TraI/TraR from Agrobacterium species. In this loop however, the 
strength of  the feedback is controllable via an externally inducible promoter. In the presence of  arabinose, the 
transcriptional regulator AraC induces expression from the PBAD promoter (30), therefore TraI expression rate 
can be controlled via an external arabinose input (araC gene is not included in Figure.2 but is intended to be con-
stitutively present in master cells). Arabinose induces expression of  TraI, which synthesises 3OC8HSL, this diffuses 
into the media and its concentration will depend on master population density. 3OC8HSL will activate TraR, in 
master cells, which in turn increases expression of  ccdB, from the PtraR promoter, reducing master population 
growth rate. This closes loop 2 by reducing the number of  cells producing 3OC8HSL, and similarly reduces the 
strength of  the feedback in loop 1. Therefore, arabinose concentration directly controls master population density 
and indirectly controls slave population density. Having ccdB expression controlled by 3OC8HSL concentration 
rather than directly by arabinose concentration allows master cells to dynamically respond to changes in their own 
population density, whilst simultaneously allowing density to be modulated as desired. 
The hypothesis was that this circuit design could perform as a control system in which the master population acts 
as a controller and slave population density is the system output (Figure 4). 3OC6HSL acts as a proxy for slave 
population density and arabinose acts as the reference signal. The difference between 3OC6HSL and arabinose (via 
3OC8HSL) concentration in the media will determine the strength of  the 3OC12HSL control signal.  ccdB expres-
















Figure 3. Population density regulating circuit design. The two engineered cell populations are regulated by QS feedback loops that control ccdB toxin expression. The master 
cell population density can be controlled via arabinose concentration in the growth media. Master cells then regulate slave cell population density via two QS molecules. Dashed lines 
represent cell walls. Arrows represent activation, synthesis or diffusion; blunt arrows represent killing. Small rectangles represent promoter regions, large rectangles - genes, ellipses - 






























Figure 4. Control system representation of  the design.  3OC6HSL acts as a proxy for slave population density and arabinose acts as the reference signal. The difference between 
3OC6HSL and arabinose (via 3OC8HSL) concentration in the media will determine the strength of  the 3OC12HSL control signal.  ccdB expression in slave cells can be viewed as 








Balagadde and colleagues developed a model of  all main reactions involved in their predator prey system including 
transcription, translation, diffusion of  HSL and regulatory protein activation; they later simplified this model to 
equations representing cell population densities and external HSL concentrations only. They concluded that due to 
large differences in the time scales of  processes in the system, this simplification did not greatly affect the behaviour 
of  the model (27). We therefore followed this approach to model our system. The circuit is modelled with a set of  
five ordinary differential equations (ODEs). These ODEs describe the dynamics of  the master population (Equa-
tion 1) and slave population (Eq. 2) and the concentrations of  the three HSLs in the media: 3OC6HSL (Eq. 3), 
3OC8HSL (Eq. 4) and 3OC12HSL (Eq. 5). Population dynamics are modelled using logistic growth equations 
including a term that makes cell death proportional to intracellular ccdB concentration. HSL production rates are 
modelled using Hill function equations, and production rate is assumed to depend directly on the external concen-
tration of  any inducer molecule. No intermediate steps including inducer protein transcription and translation, HSL 
synthesis, HSL diffusion between cells, receptor protein activation and promoter binding are explicitly included. 
This assumes that all of  these processes occur at a faster rate than the modelled processes, and therefore can be 
removed from the model to reduce complexity. For instance, the equation for 3OC12HSL concentration (Eq.5) is 
written as if  3OC12HSL production is directly activated by 3OC6HSL in the media. The intracellular concentra-
tions of  constitutively expressed proteins are treated as being constant, this assumes that these species are in abun-
dance within cells.   
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Subscript 1 refers to the master cells, and 2 refers to the slave cells, subscripts 6, 8 and 12 refer to 3OC6HSL, 
3OC8HSL and 3OC12HSL respectively; 
"# is the master population density (cells nl-1); 
": is the slave population density (cells nl-1); 
'(L  is the growth rate of  master/slave cells (hour-1); 
"-./ is the carrying capacity of  the system; 
!(L is the death rate of  master/slave cells (nM-1 ccdB hour-1); 
23M is the external HSL (3OCiHSL) concentration (nM); 
NM is a cooperativity (Hill) coefficient; 
7M is the external concentration of  the relevant signal molecule needed to half  maximally activate its cognate 
promoter (nM); 
9 is the dilution rate (hour-1); 
'>L  is the production rate of  HSL (3OCiHSL) (nM hour-1); 
!>L is the external degradation rate of  HSL (3OCiHSL) (hour-1); and 
E3  is the external arabinose concentration (nM).  
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Parameter values. Table 1 contains a full list of  parameter values used for modelling. Most initial estimates were 
taken directly from Balagadde (27) but averaged or rounded values from Balagadde were also used. Other estimates 
were made using consensus values from the literature.  
 
Table 1. Parameter values 
Parameter Description Unit 
Original 
value 
Final     
value 
'() Master population growth rate hr-1 0.5 / 
'(; Slave population growth rate hr-1 0.25 / 
!() Master cell death rate nM-1 ccdB   hr-1 0.5 / 
!(; Slave cell death rate nM-1 ccdB hr-1 0.25 / 
"-./ System carrying capacity cells nL-1 105 / 
9 Dilution rate hr-1 0.3 / 
N# Cooperatively of  3OC8HSL activation NA 2 / 
N: Cooperatively of  3OC12HSL activation NA 2 / 
NG Cooperatively of  Arabinose activation NA 2 / 
NJ Cooperatively of  3OC6HSL activation NA 2 / 
7#	
 
Concentration of  3OC8HSL necessary to 
half-maximally active PtraI promoter 
nM 10 / 
7: 
Concentration of  3OC12HSL necessary to 
half-maximally active PluxI promoter 
nM 10 / 
7G 
Concentration of  Arabinose necessary to 
half-maximally active PBAD promoter 
nM 105 1013 
7J 
Concentration of  3OC6HSL necessary to 
half-maximally   active PluxI promoter 
nM 10 / 
'>? Production rate of  3OC6HSL nM hr-1 0.1 0.001 
'>D Production rate of  3OC8HSL nM hr-1 0.1 / 
'>);  Production rate of  3OC12HSL nM hr-1 0.1 0.001 
!>A? External degradation rate of  3OC6HSL hr1 0.05 0.0005 
!>AD External degradation rate of  3OC8HSL hr1 0.05 / 




Using the original parameter estimates, with HSL production and degradation rates and activation coefficients set 
equal (Table.1), slave population density crashed at arabinose concentrations in the µM – mM range (Figure 5). In 
order to allow slave population density to rise, 3OC6HSL and 3OC12HSL production rates ('>?,'>);) were reduced 
10 or 100 fold with HSL degradation rates (!>A?,!>A);) set at half  production rate. Reducing HSL production rates 
10 fold allowed the slave population to reach higher steady state (s.s.) density (» 40,000 cells nL-1) (Figure 5). 
Reducing production rates 100 fold had the extra advantage of  reducing the time taken to reach equilibrium, so 
these rates were used for all further analyses. These reductions in production rates could be achieved in reality by 
reducing the relevant plasmid copy numbers or by selecting very weak promoters.  A bifurcation plot (using the 
adjusted parameter set) showed that while slave population now reached a high, stable density, density could not be 
controlled by altering arabinose concentration within the realistic concentration range (Figure 6). In order to con-
trol slave population density, the sensitivity of  the PBAD promoter to arabinose had to be reduced. As the arabinose 
activation coefficient (7G) was increased from 105, the control of  slave population density using the desired arabi-
nose concentrations becomes possible (Figure 7). For the following analysis 7G = 1013 was used. Some decrease in 
activation sensitivity could be achieved using a mutated transcription factor or degenerated promoter to reduce 
affinity. However, it is uncertain if  an activation coefficient as high as this could be achieved in reality. With the 
adjusted parameter set, master and slave population densities respond to arabinose concentration achieving the 
study design aims (Figures 8, 9 and 10). Populations settle at stable densities, and the densities reached can be 
altered via arabinose concentration.  S.s. Slave population density can be tuned from less than 1000 (Figure 8) to 















Figure 5. Slave population dynamics at different HSL production rates. Production rates '>?  and '>);  at 
0.1, 0.01 and 0.001 nM Hour-1 (!>A?  and !>A);   were set to equal half  production rate). Only the lower production 

















Figure 6. Steady state slave population density against arabinose concentration with original parame-
ters. Bifurcation plot, with '>?  and '>);= 0.001 nM Hour-1), showing that s.s. population density cannot be con-
trolled sufficiently via arabinose concentrations in this range. 
               '>? , '>);= 0.1 nM Hour-1 
               '>? , '>);  = 0.01 nM Hour-1 
               '>? , '>);= 0.001 nM Hour-1 
 

















Figure 7. Steady state slave population density against arabinose concentration: altered activation coef-
ficient. Bifurcation plot, with activation coefficient 7G = 106-1013, showing that 7G = 1013 allows control of  slave 
















Figure 8. Model population dynamics with arabinose = 0.1 mM. At this arabinose concentration, and with 
the functional parameter set, Master (Blue) and Slave (Red) populations reach stable densities of  approximately 
12,000 and 500 cells nL-1 respectively.  
 'G= 106 – 1010 
 
 'G= 1011 
 
 'G= 1013 
 




















Figure 9. Model population dynamics: Arabinose = 0.5 mM. At this arabinose concentration, and with the 
functional parameter set, Master (Blue) and Slave (Red) populations reach stable densities of  approximately 750 
















Figure 10. Model population dynamics: Arabinose = 1 mM. At this arabinose concentration, and with the 
functional parameter set, Master (Blue) and Slave (Red) populations reach stable densities of  approximately 500 












To ascertain which parameters are most sensitive to change, bifurcation analysis was carried out for each param-
eter in turn. The effect on s.s. slave population density of  altering each parameter for a range of  ±10% from the 
original value was determined with arabinose concentration = 0.6 mM which corresponds to a s.s. slave density of  
25,000 cells nL-1 (Figures 11-22). This provided an indication of  the robustness of  the system to noise and identi-
fied which parameters are potential targets for manipulation to improve system performance. For parameters where 
values were all equal — cooperativity coefficients (b1, b2, b3, and b4), HSL production rates ('>?, '>);) and HSL 
degradation rates (!>A?, !>A);) — all parameters were perturbed simultaneously. The following results were ob-
served: 
 
1. As can be expected intuitively from the design, the following parameters are positively correlated with s.s. 
slave population density: master cell death rate (!()) (Figure 12), slave population growth rate ('(;) (Fig-
ure 13), cooperativity/Hill coefficients (b1, b2, b3, and b4) (Figure 15), 3OCHSL6 and 3OCHSL12 degra-
dation rate (!>A?, !>A);) (Figure 19), 3OCHSL8 production rate ('>D) (Figure 20) and population carrying 
capacity (cmax) (Figure 22). While the following are negatively correlated: master population growth rate 
('()) (Figure 11), slave cell death rate (!(;) (Figure 14), activation coefficients (7#,	7:,7J) (Figure 16), 
3OCHSL6 and 3OCHSL12 production rate ('>?,'>);) (Figure 18) and 3OCHSL8 degradation rate (!>AD) 
(Figure 21). 
 
2. Master population growth rate ('()) is the parameter most sensitive to change (Figure 11), decreasing by 
10% has limited effect on s.s. slave population density, but a 10% increase results in an approximately 10-
fold reduction in s.s. slave density.  This suggests that when selecting a master strain, erring on the side of  
low growth rate would be wise. Other population change parameters ('(; ,!(),	!(;) only exert a compara-
tively moderate effect on s.s. slave population density. 
 
3. s.s. Slave population density is highest for a dilution rate of  0.31, and increasing or decreasing D lowers s.s. 
population density (Figure 17).  
 
4. All other parameters have a small or moderate effect on s.s. slave density and so are relatively robust to 















Figure 11. Parameter sensitivity analysis: Master population growth rate. Bifurcation plot showing 
the effect on steady state slave population density of  altering Master population growth rate ('()), for a range 
















Figure 12. Parameter sensitivity analysis: Master cell death rate. Bifurcation plot showing the effect 
on steady state slave population density of  altering Master cell death rate (!()), for a range ±10% from the 

















Figure 13. Parameter sensitivity analysis: Slave population growth rate. Bifurcation plot showing the 
effect on steady state slave population density of  altering Slave population growth rate ('(;), for a range ±10% 















Figure 14. Parameter sensitivity analysis: Slave cell death rate. Bifurcation plot showing the effect on 

















Figure 15. Parameter sensitivity analysis: Cooperatively coefficients. Bifurcation plot showing the effect on 
steady state slave population density of  altering Cooperatively coefficients (b1, b2, b3, and b4), for a range ±10% 
















Figure 16. Parameter sensitivity analysis: Activation coefficients. Bifurcation plot showing the effect on 


















Figure 17. Parameter sensitivity analysis: Dilution rate. Bifurcation plot showing the effect on steady 
















Figure 18. Parameter sensitivity analysis: 3OCHSL6 and 3OCHSL12 production rate. Bifurcation 
plot showing the effect on steady state slave population density of  altering 3OCHSL6 and 3OCHSL12 produc-

















Figure 19. Parameter sensitivity analysis: 3OCHSL6 and 3OCHSL12 degradation rate. Bifurcation 
plot showing the effect on steady state slave population density of  altering 3OCHSL6 and 3OCHSL12 degra-















Figure 20. Parameter sensitivity analysis: 3OCHSL8 production rate. Bifurcation plot showing the 
effect on steady state slave population density of  altering 3OCHSL8 production rate ('>D), for a range ±10% 

















Figure 21. Parameter sensitivity analysis: 3OCHSL8 degradation rate. Bifurcation plot showing the 
effect on steady state slave population density of  altering 3OCHSL8 degradation rate (!>AD), for a range ±10% 















Figure 22. Parameter sensitivity analysis: Population carrying capacity. Bifurcation plot showing the 
effect on steady state slave population density of  altering Population carrying capacity ("-./), for a range ±10% 





The simulation demonstrates that this circuit design for regulating bacterial populations can function at least 
theoretically. Modelling results show that our simple design can perform the specified aims of  maintaining stable, 
but different, densities of  two populations and allowing s.s. densities to be tuneable through an external input. 
Parameter analyses provide some insight into functional parameter ranges and potential targets to modify perfor-
mance. To put the design into practice, the genetic components of  the circuit could be assembled on three plasmids: 
a TraI, TraR and ccdB expression plasmid for self-regulation, contained within the master cells; a LuxR and LasI 
slave regulating plasmid, contained within master cells; and a LuxI, LasR and ccdB plasmid, within slave cells. This 
conformation would provide modularity allowing only the components required for a given task to be used. For 
example, a single population system would only require the self-regulation plasmid. This design could also be ex-
tended to regulate multiple populations by introducing variants of  the slave plasmid into multiple slave strains, a 
consortium with many strains existing at various densities could be created. Similar circuits could be designed for 
yeast and mammalian cells, by using pheromones and growth factors or secondary messengers, respectively, for 
inter-cellular communication (7). 
 
In theory, circuits like this could allow us to create multi-population systems that function autonomously and can 
adapt to variation in conditions. There are many potential applications of  a functioning circuit of  this type. As a 
concrete example, Goyal and colleagues used a consortium of  four yeast strains to produce ethanol from cellulose. 
To produce optimal yield, strains had to be cultured individually before being mixed at specific ratios (31). For a 
bioprocess like this to be industrially feasible, a means of  keeping the ratio stable over a long period is clearly 
necessary.  There have been several reports of  cell signalling systems being co-opted to facilitate microbial coexist-
ence. While our system relies on interactions that decrease survival, other researchers have modelled and built sys-
tems that use mutual rescue to force obligate mutualism and co-survival of  strains (32, 33). It would be interesting 
to compare the properties of  each approach. Yet another way of  using multiple strains to carry out a process is to 
create spatial or temporal separation. Each solution will have its own pros and cons and may be best suited to 
certain applications. 
 
Our design is very simple and suffers from some limitations. For instance, the exact s.s. population densities for 
a given arabinose input cannot be known beforehand and would need to be determined experimentally. A more 
tightly controlled system could be created by adding a circuit designed to act as a direct comparator, to compare the 
reference signal with active TraR or LuxR concentration, but this would also increase the complexity of  the circuit, 
which entails its own problems. In our design, the ratio between master and slave populations and absolute popu-
lation densities cannot be controlled independently. One way to alter this would be to introduce another external 
induction molecule to regulate the strength of  master feedback to slave cells, but this would perhaps negate the aim 
of  having interacting populations. Sensitivity analysis demonstrated that deviations from estimated parameter val-
ues, especially master population growth rate, greatly affect the outcome and therefore care would be needed to 




overall the design is robust. One limitation of  all multi-cell synthetic circuits is the lack of  available signalling mol-
ecules and this is a problem that will need to be addressed to create complex networks. 
 
Towards the long-term goal of  creating synthetic microbial consortia with stable populations, our next objective 
is to assemble and test this network design in vivo. Our design intentionally uses circuit parts that have already been 
assembled and demonstrated working. An initial goal would be to show stable populations in a microfluidics device 
or micro-chemostat, before scaling up to larger cultures. Research into synthetic consortia is an exciting field, and 
has innumerable potential applications. An interesting parallel is occurring in swarm robotics, where instead of  
creating single complex robots, multiple interacting independent agents, each following simple algorithm, have been 
shown to produce complex emergent behaviours (34). We may therefore expect to see many promising develop-
ments in multi-population synthetic networks.  
 
  ABBREVIATIONS 
  QS, Quorum Sensing; GRN, Gene Regulatory Network; HSL, Homoserine Lactone; S.S., Steady State; ODE, 
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Controlling Meiotic Recombination in Plants with RNA Guided Cas9 
 
ABSTRACT 
In sexually reproducing species, meiotic recombination produces novel allele combinations, generating genetic 
variation in offspring. Plant breeding relies on this variation for crop improvement. However, recombination events 
are stochastic and recombination rates between certain genes are often very low. The ability to manipulate the rate 
and location of  recombination events within plant genomes would therefore provide a great breakthrough for crop 
improvement.  
Meiotic recombination begins with the formation of  double stranded breaks (DSBs) in aligned chromosomes 
catalysed by the highly-conserved protein Spo11. Plants with inactivating mutations in Spo11 have greatly reduced 
fertility. The endonuclease Cas9 combined with a single guide (sg)RNA can produce targeted DSBs in plants; there-
fore, it presents an attractive potential means to manipulate meiotic recombination, by reproducing the activity of  
Spo11.  
The long-term goal of  this study was to test the hypothesis that: targeted DSBs in aligned homologous chromo-
somes during meiosis, catalysed by a Cas9:sgRNA complex, can trigger recombination at a desired locus. This could 
be tested by transforming Arabidopsis thaliana Spo11 mutant plants with a construct containing Cas9, driven by a 
meiocyte-active promoter, and a sgRNA targeting multiple sites throughout the genome. In theory, the activity of  
Spo11 could be artificially replaced and evidenced by the recovery of  fertility in T1 plants homozygous for a Spo11 
mutation. This would provide a proof  of  concept that could be applied to crops for the advancement of  crop 
breeding. 
As a first step towards this goal, a Cas9:sgRNA expressing binary vector was assembled and a published edit was 
replicated in Arabidopsis, to confirm that the construct was able to generate DSBs. Editing results were disappointing 
and are presented and discussed here. Also, Spo11 mutant Arabidopsis lines were acquired and mutations verified. 
 
BACKGROUND 
In sexually reproducing species, meiotic recombination produces novel allele combinations, generating genetic 
variation. Plant breeding relies on this genetic diversity for crop improvement: crosses produce offspring with new 
combinations of  beneficial alleles and useful genes from wild relatives can be introgressed into high yielding varie-
ties, to introduce traits such as pest resistance or draught tolerance (1). However, recombination events are stochas-
tic and recombination rates between certain genes are often very low — because genes are in close physical prox-
imity to one another on the chromosome (linkage drag) or in cold spots on chromosomes, where very little recom-
bination occurs (2) —which limits the speed and efficiency of  plant breeding. Although crop breeding has been 
greatly accelerated by advances in technologies such as marker assisted selection, ultimately it still relies on natural 
meiotic recombination to shuffle DNA, with all its associated infrequency and stochasticity. The ability to manipu-
late the rate and location of  recombination events within plant genomes would therefore provide a great break-




in a chromosome catalysed by the protein Spo11. The CRIPSR/Cas9 system can produce targeted DSBs in plants; 
therefore, it presents an attractive potential means to manipulate meiotic recombination. 
Meiotic Recombination 
Meiosis consists of  a single round of  DNA replication followed   by   two   rounds   of    nuclear   and cellular 
division, producing four gametes with half  the ploidy number of  the parent cell. Meiosis 1 segregates homologous 
chromosomes, meiosis 2 then segregates sister chromatids and fertilisation restores ploidy in the zygote to the 
parental number. Meiotic recombination takes place during prophase of  meiosis 1, facilitated by chromosomal 
crossover — the reciprocal exchange of  corresponding sections of  DNA between homologous chromosomes — 
which is physically manifested by the appearance of  chiasmata between homologues aligned at synapsis (4). Meiotic 
recombination is controlled by a complex set of  interacting proteins, initiated by the highly-conserved protein 
Spo11 catalysing a DSB in one of  the homologues (5–8) (Figure 1). Only a subset of  these breaks will be resolved 
as cross over events (9). A suite of  proteins then orchestrates: resectioning of  DNA near the DSB, leaving single 
stranded DNA; strand invasion of  the homologous sequence; templated repair; and finally cutting to release the 
recombined homologues (1). Chromosomal crossover facilitates synapsis and chromosomal alignment at the mei-
ocyte equator during meiosis 1, and is therefore necessary for the correct segregation of  homologues into daughter 
cells (10). An absence of  crossovers results in aneuploid daughter cells and reduced fertility (11–13). 
In Arabidopsis thaliana, megasporocytes undergo meiosis inside the ovary, with only one of  the four daughter cells 
surviving as a single megaspore which develops into an embryo sac — the female gametophyte. Within the anther, 
microsporocytes undergo meiosis producing four microspores, each of  which develops into a pollen grain — the 
male gametophyte (14). In Arabidopsis there are three   Spo11   homologues, two of  these, AtSPO11-1 and AtSPO11-
2, are believed to function in the formation DSBs during recombination (11,12,15–18). Plants homozygous for a 
knock out mutation in either Spo11-1 or Spo11-2 have short siliques and have greatly reduced fertility; furthermore, 
plants heterozygous for a knockout at both Spo11-1 and Spo11-2 show a similar loss of  fertility (11–13,18). Spo11 
mutants therefore present a potential test system for artificially induced meiotic recombination. If  recombination 














Figure 1. Key stages of  meiotic recombination as elucidated in A. thaliana.  Showing, the potential non-
crossover (NCO) and crossover (CO) outcomes of  the process. Proteins known to be involved at each stage are 
listed on the right; note AtSPo11-1/2 at double strand break (DSB) formation. Image taken from (10). 
 
The CRISPR/Cas9 System 
The RNA guided Cas9 system has been demonstrated as an efficient method to create targeted genome edits in 
plants (19–25).The system comprises of  two components:  the Cas9 nuclease, which catalyses the formation of  
DSBs in DNA and the single guide RNA (sgRNA), which provides target specificity by the binding of  a 20 nucle-
otide ‘guide sequence’, at its 5’ end, with a complementary ‘target sequence’ in the genomic DNA, while a ‘scaffold 
sequence’, at its 3’ end, forms  a secondary structure capable of  recruiting the Cas9 protein to the target (26) (Figure 
2). The Cas9 protein contains two nuclease domains: HNH and RuvC which cleave the DNA target- and non-





The system is derived from the CRISPR:Cas9 adaptive immune system of  Streptococcus pyogenes and much of  the 
terminology used can be confusing due to parallels between the functioning of  the natural system and of  the 
artificial genome editing system (27,28). In the natural system of  bacteria, DNA regions termed clustered regularly 
interspaced short palindromic repeat (CRISPR) arrays consist of  partially palindromic repeats interspersed with 
unique ‘spacer’ sequences. It was discovered that a short sequence of  invading viral DNA termed a ‘protospacer’ is 
excised by CRISPR associated (Cas) proteins, Cas1 and Cas2, and incorporated into the CRISPR array to create a 
new spacer. Upon a future viral infection, the CRISPR array region is transcribed into an RNA which is then pro-
cessed by other Cas proteins into a CRISPR (cr)RNA — derived from the spacer DNA — and a trans-encoded 
CRISPR (tracr)RNA — derived from the CRISPR DNA sequence. The crRNA and tracrRNA join via a short 
complementary sequence to form a structure able to recruit Cas9 to cleave the invading DNA (27,28). When the 
system was appropriated for genome editing, it was found it could be simplified by expressing the crRNA and 
tracrRNA as a single guide (sg)RNA (26). Therefore, the guide, scaffold and target sequences referred to in the 
editing literature can be thought of  as equivalent to the spacer/crRNA, CRIPSR/tracrRNA and protospacer se-
quences respectively, of  the natural system. In bacteria, to prevent Cas9 cleaving the host genome at the CRISPR 
array, a DNA binding domain of  Cas9 needs to recognise a 3 base pair sequence directly adjacent to the protospacer 
sequence, termed the ‘protospacer adjacent motif ’ (PAM) which is not present in the CRIPSR array. The canonical 
PAM of  S. pyogenes Cas9 is NGG and the presence of  this sequence directly following the selected target sequence 
is the only prerequisite when choosing a target editing site (26).  
 
 
Figure 2. Components of  the CRISPR/Cas 9 system. crRNA, (a) Shows separate CRISPR (cr)RNA and 
trans-encoded CRISPR (tracr)RNA as in the natural system. (b) Shows the RNA components combined as a single 
guide (sg)RNA as used the majority of  genome editing studies. The Cas9 protein is shown in grey with the HNH 






sgRNA:Cas9 Editing in Plants 
Arabidopsis comes second to rice (Oryza sativa), in terms of  the greatest number of  reported edits for a plant 
species (29). In Arabidopsis, RNA guided Cas9 has been used to produce edits in protoplasts, and to create stable 
heritable edits in whole plants (19,21–24,30–41). Most studies have been performed with the sgRNA and Cas9 
sequences in the same T-DNA construct, which is integrated into the plant genome via Agrobacterium mediated 
transformation using the floral dip method (42). The most popular promoter choice for Cas9 has been CaMV 35S 
or double CaMV 35S, and sgRNAs are usually expressed from Arabidopsis U6 small nuclear RNA (snRNA) pro-
moters, which are transcribed by RNA polymerase III (23,43–45). The most frequently performed type of  editing 
relies on the endogenous DNA repair pathway of  Non-Homologous End Joining (NHEJ) which is error prone 
and so will often result in short insertions/deletions (indels) at the site of  a single DSB created by Cas9. This 
technique is commonly used to create ‘knock outs’ via frame shifts and genes or alternatively to delete a longer 
section of  DNA by making two flanking cuts (21,25,31,38,46–48). A second method utilizes the Homology Di-
rected Repair (HDR) pathway to introduce a desired sequence into the genome (Gene Targeting, GT); to achieve 
this, a template with flanking regions homologous to genomic sequences either side of  the cut site needs to be 
introduced to the cell, in addition to the Cas9:sgRNA construct. While this method offers a greater flexibility of  
possible genome alterations, it is much harder to apply, and the proportion of  plants showing the alteration is far 
lower than with NHEJ(49).  
Project Aims 
The long-term goal of  this study was to test was the hypothesis: that by transforming Arabidopsis Spo11 mutants 
with a Cas9:sgRNA construct expressed during meiosis, the activity of  Spo11 could be replaced and fertility would 
be recovered. A published Cas9:sgRNA construct would be modified to have Cas9 driven by a meiocyte-active 
promoter and with a sgRNA targeting a sequence present at multiple sites throughout the genome. T0 plants heter-
ozygous for a Spo11-1 or Spo11-2 knock out mutations were to be transformed using Agrobacterium mediated trans-
formation. DSBs created in aligned homologous chromosomes in meiocytes of  Spo11 -/- T1 plants could theoret-
ically trigger recombination and  recover fertility. 
As a first step towards this long-term goal, a Cas9:sgRNA expressing binary vector was obtained and an attempt 
made to replicate an edit from the  original publication (47) in Arabidopsis, to confirm that the construct was able to 
generate DSBs. The editing ability of  the construct was tested at a single-locus, replicating as closely as possible the 
published methods. Had the editing ability been verified, the construct promoter would have been swapped for a 
meiotically active promoter and the sgRNA would have been changed to target a sequence present in all chromo-
somes: in order to move on to the aspirational recombination experiments in Spo11 mutants. Spo11 mutant lines 






MATERIALS AND METHODS 
Selection of  Cas9:sgRNA Vector 
A number of  Cas9:sgRNA binary vectors have been created for Arabidopsis; these differ in terms of  the species 
Cas9 is codon optimized for, choice of  promoters driving Cas9- and sgRNA expression and choice of  binary vector 
backbone (29). For this study, a construct created by Ma et al. (47) was selected based on the following criteria: the 
construct had been verified for editing ability in Arabidopsis; gene editing efficiency was reportedly high; details of  
the methodology used are clear from the publication; and the construct was designed to allow straight forward 
insertion of  a new guide sequence into the sgRNA cassette. To confirm that the published editing results were 
repeatable, an editing experiment from the original paper was replicated, keeping all steps as close to those reported 
as possible. The two plasmids needed to assemble a binary vector carrying Cas9 and sgRNA were purchased from 
Addgene (catalogue numbers 66191 and 66203), these are pYLCRISPR/Cas9P35S-N and pYLsgRNA-AtU6-29, 
and are based on pUC18 and pCAMBIA1300 backbones respectively. pYLsgRNA-AtU6-29 is an intermediate vec-
tor carrying a sgRNA expression cassette, and pYLCRISPR/Cas9P35S-N is a binary vector that carries, between 
T-DNA borders: the Cas9 gene (codon optimised for rice and expressed from a double CaMV 35S promoter, with 
nuclear localisation sequences at each end); the plant selectable marker gene neomycin phosphotransferase II; and 
an insertion site for the sgRNA expression cassette (between two BsaI restriction sites, that flank a toxic ccdB  gene 
which acts as a negative selectable marker).  
Selecting a Target Sequence 
The target sequence previously selected by Ma et al. is in gene At5g55580, which encodes a putative mitochon-
drial transcription termination factor protein (mTERF), of  unknown function. Sequence: 
GATGAGTTCGAGGAAGTATG(TGG) — the three bases in brackets are the PAM sequence.  
Ma et al. reported that 3 out of  9 T1 plants, carrying the T-DNA insert and screened at this locus, showed evi-
dence of  editing events (2 heterozygous and 1 biallelic), and that some plants with mutations in this gene showed 
albino phenotypes, from which they concluded that the gene is essential for chloroplast biogenesis. 
Plasmid Assembly 
For full details of  assembly steps see Ma et al. (47). Briefly: two oligos corresponding to the two strands of  the 
20 base pair guide sequence flanked by BsaI restriction sites were synthesized by Eurofins (At-1F: 
ATTGATGAGTTCGAGGAAGTATG and At-1R: AAACCATACTTCCTCGAACTCAT); these were annealed 
and the resulting guide sequence was cloned into plasmid pYLsgRNA-AtU6-29 to give a functional sgRNA ex-
pression cassette. A nested PCR was performed with this modified pYLsgRNA-AtU6-29 as a template, using two 
sets of  flanking primers to create an amplicon of  the complete sgRNA expression cassette 
(1st PCR: U-F: CTCCGTTTTACCTGTGGAATCG and gR-R: CGGAGGAAAATTCCATCCAC;  
2nd PCR Pps-GGL: TTCAGAGGTCTCTCTCGACTAGTATGGAATCGGCAGCAAAGG and Pgs-GGR: 




The primers of  the second PCR round introduced BsaI restriction sites that gave sticky ends compatible with 
insertion into the vector pYLCRISPR/Cas9P35S-N. Finally, the PCR amplicon was cloned into pY-
LCRISPR/Cas9P35S-N to replace the ccdB gene and create a Cas9 : sgRNA binary vector, hereafter referred to 
as Construct 1 (Figure 3). Construct 1 was verified by Sanger sequencing.  
 
Figure 3. Plasmid map of  Construct 1 – used to create an edit in gene At5g55580. NLS = Nuclear localisation 
sequence (SV40 at start: nucleoplasmin at end), Ori = Origin of  replication, Kan-R = Kanamycin resistance gene, 
Neo-R = Neomycin/G418 resistance gene (Neomycin phosphotransferase II). 
 
Growing Plants  
All plants used were Col-0 ecotype. For floral dipping, plants were grown as “muffins” in 3’’ pots in a 3:1 mix of  
compost : sand, and grown in greenhouse conditions  at 21°C with 16 hours light, 8 hours dark cycles under cool, 
white fluorescent bulbs at a light intensity of  approximately 100 mmol m-2 s-1. For all other experiments, plants 
were grown in 4, 4, 5 cm trays under the same conditions. All seeds were stratified for 48 h in darkness at 4°C prior 
to planting. 
Agrobacterium Transformation 
The complete Cas9:sgRNA construct (Construct 1) was introduced into Agrobacterium tumefaciens strain GV3101 
by electroporation, and transformation of  six week old flowering Arabidopsis was performed as described previously 
(42). 25 plants were treated (5 muffins x 5 plants per muffin). Plants in a sixth untreated muffin were used as 
controls. 
Selection of  Transformed Plants 
T1 seeds were surface sterilized by submerging in 70% ethanol for 5 minutes and rinsing in 3 washes of  distilled 




mL-1 G418 for selection, approximately 1000 seeds per 90mm diameter plate x 5 plates ( 16 seeds cm-2 ). Plates were 
stratified and kept in a controlled growth room at 21°C with 16 hours light, 8 hours dark cycles under cool, white 
fluorescent bulbs at a light intensity of  approximately 100 mmol m-2 s-1. After 10 days, healthy looking seedlings 
were transferred to soil and grown as above. 
PCR Screening Transformed Plants 
An approximately 0.5 cm diameter section of  one of  the first true leaves was taken from each plant for gDNA 
extraction. Integration of  the T-DNA was confirmed by performing a PCR with primers specific to the Cas9 gene 
(pYLCas9-3F: GATGGACTGGTGGATGAGAGT and pYLCas9-4R CATCGACAACAAGGTCCTCAC) to 
produce a 1504 base pair amplicon.  
Sequencing to Detect Edits 
PCR amplifications were carried out using primer pairs flanking the At5g55580 target site (Ed1P1-F: 
CTTTAGGATGATTTCGCTGAGG and EdP1-R GGAATTAGGAATGCCAAGACCC) to produce a 689 base 
pair amplicon. The PCR products were Sanger sequenced using the same primers. Evidence of  an editing event can 
be detected by analysing the sequenced chromatograms by eye; the sudden appearance of  double peaks at the target 
sequence, with a reduction in quality scores for the following sequence indicates a potential editing event (47). 
Verification of  Spo11-1 and Spo11-2 Mutants 
Spo11-1 and Spo11-2 mutants were purchased from the Arabidopsis stock centre (Lines SALK_146172 and GABI 
749C12). To bulk seed and verify the correct mutations were present, plants were grown and screened by performing 
a PCR with primers specific to the T-DNA insert and relevant Spo11 locus:- 
Primers used were: for Spo11-1 wild type amplicon SALK172-F: TTTCAGTGTAGTCGGTACAACTTGAATG- 
TG and SALK172R: CCACAACCAGTATGTACTCAGCTAAGCTAAC; for Spo11-1 T-DNA insertion amplicon 
SALKLBb1: GCGTGGACCGCTTGCTGCAACT and SALK172R; for Spo11-2 wild type amplicon P1: 
TCCTGATCTGCCAATTCTTG and P2: CCATGACAATAGAGAGCTTC; for Spo11-1 T-DNA insertion am-





40 T1 plants were grown: 36 putative transformants from selection plates and 4 control plants (the offspring of  
plants grown under the same conditions but not inoculated with Agrobacterium). The plants were screened for T-
DNA integration by PCR with Cas9 specific primers, and all except two of  the 36 putative transformants produced 
an amplicon of  the correct size (Figure 4), the two plants with no amplicon could be plants without the T-DNA 
insert that somehow survived selection, or the lack of  an amplicon could simply be down to a failure at some stage 
of  the gDNA extraction or PCR preparation, the two plants were omitted from further analysis. This gives a suc-
cessful transformation rate of  0.8%, which is consistent with published results (42). The 34 positive plants were 
Sanger sequenced for a region including the target editing site; only one had detectable evidence of  an editing event. 
The chromatogram of  plant 33 had visible but weak secondary peaks appearing from 4 bases before the PAM 
sequence; 3 base pairs before the PAM is documented as having the highest probability of  a mutation 
(19,20,22,24,25,40,44,50). Inspection shows that the second set of  peaks is consistent with a single base pair inser-






Figure 4. Gel of  the products of  PCR for putative transformants. Performed with primers specific to the 
Cas9 gene (primers pYLCas9- 3F and 4R) from the gDNA of  putative transformants; with the exceptions of  plants 
1-4 which are Agrobacterium unexposed controls, and plants 26 and 30, all plants have an amplicon of  the expected 
size (1504 bp), indicating successful integration of  the Cas9:sgRNA construct. –ve = water control, +ve = original 





Figure 5. Chromatogram of  the putative editing site of  plant 33. Produced by sequencing the genomic DNA 
of  plant 33 at the target editing site in gene At5g55580. An extra set of  peaks appear from four base pairs before 
the PAM sequence and this new sequence is consistent with an insertion of  an extra A. 
 
Original sequence: GATGAGTTCGAGGAAGTATGTGGAGAAACTATACCCTCGGCTCGC 
New sequence:       GATGAGTTCGAGGAAGATATGTGGAGAAACTATACCCTCGGCTCGC 
Plasmids with Meiotically Active Promoters 
Had the single-locus editing experiment produced satisfactory results, the next step toward the long-term exper-
imental goal of  generating  multiple DSBs in meiocytes — to test the hypothesis that recombination can be artifi-
cially triggered — would require modifications to Construct 1. To create DSBs during meiosis, Construct 1 needed 
to be modified to have Cas9 expressed from a meiocyte-active promoter and to include sgRNAs which target a 
sequence that occurs 500-1000 times throughout the Arabidopsis genome (this matches estimates of  the number of  
crossovers occurring in Arabidopsis (52)). In total, three constructs were designed and partially assembled, with three 
different promoters shown to be preferentially expressed in meiocytes. These promoters were selected from a study 
by Li et al. (53) and were first identified as meiotically active using transcriptome analysis and then verified by cloning 
into a GFP reporter construct and checking for fluorescence in meiocytes. The promoters are: 
 
1. PMS5, The MS5 gene is expressed throughout meiosis and is essential for male meiosis. 
2. PAT1G15320 expression is limited to later meiosis 
3. PAT4G40020 expression is limited to early meiosis 
 
Therefore, PAT4G40020 is the promoter most likely to drive Cas9 expression at the correct time and to rescue 
fertility. Of  course, an obvious way to ensure Cas9 expression is at the correct time would be to use the endogenous 
Spo11 promoter, but this has its own inherent problems in terms of  little information about its functioning being 






Promoter regions were PCR amplified from Col-0 genomic DNA, using primers designed by Li et al. (53) modified 
to add restriction sites compatible with cloning into Construct 1 or pYLCRISPR/Cas9P35S-N. The PMS5 PCR 
product was cloned into Construct 1 to make pMS5-Construct1 (Figure 6), and this construct has been sequenced. 
However, due to non-specific amplification and problems experienced with gel extraction, and time limitations, the 
other plasmids were not assembled. 
 
 
Figure 6. Plasmid map of  pMS5-Construct 1 – a modified version of  Construct 1 with the promoter sequence 
of  the MS5 gene replacing the CaMV 35S promoter. NLS = Nuclear localisation sequence (SV40 at start: nucleo-
plasmin at end), Ori = Origin of  replication, Kan-R = Kanamycin resistance gene, Neo-R = Neomycin/G418 
resistance gene (Neomycin phosphotransferase II). 
 
Verification of  Spo11-1 and Spo11-2 Mutants 
Spo11-1 and Spo11-2 mutant lines – SALK_146172 and GABI 749C12 – were grown and screened by performing 
a PCR with primers specific to the T-DNA insert and relevant Spo11 locus. All results indicated lines were segre-





The evidence of  editing in plant 33 supports the ability of  the construct to create DSBs; however, our editing 
efficiency was far lower than that reported by Ma et al. (47) - 1/34 plants compared to 3/9 plants. The methods 
used here replicated those of  the original publication, so it unclear why there is such a large discrepancy. Also, the 
secondary peaks of  the chromatogram of  plant 33 are much smaller than those illustrated by Ma et al., and this 
would indicate chimeric plants with only a small proportion of  total cells deriving from an editing event. Ma et al. 
reported heterozygous or biallelic mutations which would give two sets of  peaks with comparable heights. Other 
reports suggest chimeric T1 plants are the most common outcome of  Cas9 editing Arabidopsis using similar meth-
odology, and the methods employed to detect edits usually take account of  this by using PCR based detection 
methods that amplify edited sequences amongst a background of  none edited cells (25,31,34,46,50,51). This begs 
the question of  why Ma et al produced such efficient results, one explanation would be that some detail of  their 
methods encouraged edits at a very early stage of  T1 plant development.  
The results suggest that Construct 1 is capable of  creating gene editing events in Arabidopsis that can be detected 
in T1 plants, but that the construct is not very efficient and that edits will have a low probability of  being heritable. 
Plasmid assembly was easily achieved and the whole plasmid was sequence verified. The floral dip was also success-
ful, evidenced by a high proportion of  transgenic T1 plants verified by antibiotic selection and PCR for the T-DNA. 
Therefore, the problems would appear to be in expression of  Cas9 or sgRNA within transformed cells, or the 
functioning of  the editing complex. 
Design Weaknesses 
In light of  recently published papers on Cas9 editing Arabidopsis, several weaknesses of  our experimental design 
become apparent. 
The first problem is the choice of  promoter. As mentioned earlier, Cas9 editing studies in Arabidopsis have often 
produced chimeric T1 plants; this is probably because the widely used CaMV35S promoter is only active in later 
stages of  plant development. The CaMV35 promoter is not known to be active during early development and 
therefore Cas9 is expressed too late to generate edits that will pass to all cells. Several papers have reported this 
finding and improvements with promoters active in early development. Examples are the EC1 promoter (38) and 
pAT4G40020 (53). Studies have shown that by expressing Cas9 from a promoter active in earlier development 
editing appears in a greater proportion of  T1 plants and homozygous mutations are far more frequent (38,40,53). 
Therefore, an interesting side line to this study would be to test the meiosis promoter constructs on the target used 
for Construct 1. Theoretically, any edit made during meiosis should be passed to all cells, and this could be much 
more efficient than the CaMV35S driven construct for general editing purposes. 
Two plasmid designs, with different promoters driving Cas9 expression, have now emerged as the most frequently 
used to edit Arabidopsis: 1) pHEE401 using the EC.1.2 promoter from Wang el al. (38). The authors trialled the 
EC1.2 promoter in combination with different terminators and enhancers, and achieved around 10% triple homo-
zygous or biallelic mutants in T1 plants, with the best combination. 2) pEn-Chimera using promoter pDE-pUbi-
Cas9 from Fauser et al. (35). The authors tested the potential to edit Arabidopsis with Cas9 as nuclease and with a 
modified Cas9 as a nickase. Using the nuclease, approximately one third of  reads from deep sequencing were edited. 




The second weakness in our plasmid design was that it included only one sgRNA sequence; most published 
studies have used two sgRNAs, targeting sequences in close proximity in the target region. It is easy to see how this 
redundancy gives improved editing efficiency: firstly it is known that editing efficiency is highly variable between 
sgRNAs (20); therefore, two sgRNAs gives a greater chance that one of  sequences will be efficient. And secondly 
it is known that the majority of  repairs of  DSBs are perfect repairs, and so two sgRNAs give the additional chance 
that two synchronous DSBs will result in a short deletion (25,34,40,46,51).  
Another issue in the experimental design, that could account for our findings, is the method of  screening: Sanger 
(direct) sequencing is likely to miss many chimeric plants if  edited cells are greatly outnumbered by non-edited cells. 
Indeed, for plant 33 the secondary peaks in the chromatogram are small in comparison to the wildtype peaks, 
showing that the editing could have been easily overlooked. Screening for edits in this way is not only prone to miss 
chimeric editing but is also time consuming, leading to a small number of  plants being screened. Many studies get 
around these problems by pooling DNA from batches of  plants and then either deep sequencing or using assays 
based on selective restriction digests at the target site followed by PCR. Both methods are more sensitive to chimeric 
plants and can be used to screen large numbers of  plants. Positive batches can then by subdivided, and edited plants 
homed in on. Future work should use a combination of  these screening methods. Additionally, targeting of  a gene 
that will give a visual phenotype change is useful for ease of  screening. Our study focused on an edit with a pheno-
typic effect but other target genes have been utilised in more than one study and therefore may be more reliable. 
An often-used target is the PDS3 gene, as it gives albino dwarf  phenotype and future work could move to this 
target as multiple reports of  successful target sequences exist (31,35,37). 
There are other potential explanations for the performance of  the editing construct, such as: choice of  sgRNA 
promoter, codon optimisation of  Cas9 and choice of  target sequence. However, none of  these seem as likely a 
cause as the three issues mentioned above, based upon the importance of  variables mentioned in the literature. A 
more controlled, but time consuming, protocol for the development of  a new editing construct for Arabidopis could 
include an in vitro assay of  sgRNA binding using restriction digest – PCR, Surveyor or T7 assays, and test of  editing 
efficiency in protoplasts.  
Future Work 
Interesting results can still be gained from plant 33: seed has been harvested from the plant and a simple antibiotic 
screen could provide evidence of  the heritability of  the T-DNA. Any resistance would demonstrate that T-DNA 
had indeed stably integrated, and the ratio of  resistant to non-resistant seedlings would give an indication of  the 
number of  insertions. Screening T2 plants, from plant 33 and other T1 plants, for editing events would give further 
evidence to hypotheses about the somatic nature of  the editing achieved with Construct 1. 
 
To date, CRISPR/Cas9 editing in Arabidopsis has not settled on any one set protocol or plasmid design, and there 
has been no side by side test of  the most widely used plasmids, to our knowledge. Therefore, plasmid designs that 
stand out in the literature could be tested for editing efficiency under the same conditions and for the same target 
sequence. Assuming efficient germ line edits can be achieved with at least one of  the plasmids, the three meiocyte 




Towards achieving our long-term goal, an alternative construct design would comprise an inactive ‘dead’ Cas9 
(dCas9) fusion with the native SPO11 protein. There are several underlying assumptions in the hypothesis that 
DSBs created by Cas9 in meiocytes can recover fertility in Spo11 mutants — even overlooking the problems of  
achieving DSBs precisely during meiosis. SPO11 is known to have roles other than DSB creation; it also known to 
recruit other proteins involved recombination to the site of  the break (11-13). Therefore, a fusion protein including 
SPO11 could circumvent this limitation. Also, it is known that most DSBs formed during meiosis do not result in 
recombination, but are repaired via other pathways (1,2,9,10). A SPO11-GAL4 fusion protein has already been 
demonstrated to increase meiotic recombination rate in yeast Saccharomyces cerevisiae (5). 
Another consideration must be that given the difficulty of  Cas9 editing in Arabidopsis, it may be more efficient to 
attempt gene targeting or manipulation of  meiotic recombination rate in crop species directly. Certainly, the litera-
ture suggests that CRISPR/Cas9 editing can be achieved more efficiently in a number of  crop plants including rice 
and barley (32,34). 
Despite its difficulties, the goal of  genome engineering plants using RNA-guided Cas9 has huge potential for 
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